What we are studying
This study is designed to evaluate the safety, tolerability and efficacy of ATI-50002 Topical Solution (twice daily for 24 weeks) in subjects with stable patchy alopecia areata (AA). Subjects will receive one of the following: ATI-50002 Topical Solution, 0.46%, ATI-50002 Topical Solution, 0.12%, or Vehicle/Placebo Topical Solution. You will not know which group you will be in.
$75.00 for each completed visit